Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Portugal Looks Forward to Standing Out as a Medical Marijuana Hub

Portugal is rapidly emerging as a leading center for medical marijuana in Europe. Its mild, temperate, subtropical environment, frequently likened to that of California, makes it an excellent location for cultivating cannabis.

“No other European country offers better environmental conditions,” said Martins of FAI Therapeutics, a Portuguese pharmaceutical firm. Located near the hills of Serpa, surrounded by cork oaks and olive trees, FAI Therapeutics’ 13.3-acre farm produces approximately 30 tons of marijuana flowers annually. The operation began in 2022 following a surge of interest from international marijuana producers drawn to Portugal’s ideal climate and supportive legislation.

Currently, over 60 companies have received authorization to cultivate, distribute, or process medical marijuana products in Portugal, with an additional 170 companies waiting for approval. Last year, the country exported about 12 tons of marijuana-based medical products, primarily to Germany, Europe’s biggest market, and to countries such as Australia, Poland, and Spain.

The industry has ambitious goals as demand for medical marijuana grows globally. According to Jose Tempero, medical director of Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), a global corporation based in Canada with a marijuana farm close to Cantanhede, Portugal is leading among European producers of medical cannabis. Tilray’s facility has packaging and processing facilities as well as labs, with its marijuana oils selling even in Latin America.

The expanding market for medical marijuana is driven by its applications in managing chronic pain, cancer treatment side effects, and certain forms of epilepsy, among other medical conditions. Over 50 countries have approved marijuana-based medications, with the number expected to increase in the coming years. Market analysts predict the global medical marijuana industry will grow from $16.6 billion in 2023 to more than $65 billion by 2030.

Beyond its favorable climate, Portugal offers a robust regulatory framework established under its 2019 cannabis legislation, which enforces strict quality standards. These regulations have bolstered confidence among international buyers, ensuring the safety and reliability of products exported from Portugal.

Despite Portugal’s leadership in production, many Portuguese patients face challenges in accessing cannabis-based medications. Most doctors are hesitant to prescribe these treatments, and their costs are not fully covered by the nation’s healthcare system. Lara Silva, whose young daughter suffers from severe epilepsy, highlighted the difficulty of accessing CBD products locally. She initially had to source them from Spain due to insufficient availability in Portugal.

Tempero acknowledged the stigma surrounding medical cannabis but expressed optimism about its growing acceptance, particularly beyond recreational use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Pennsylvania House Democrats Give Marijuana Legalization Another Go

Democrats in Pennsylvania are making another attempt to legalize cannabis through new legislation spearheaded by state Representatives Dan Frankel from Allegheny County and Rick Krajewski from Philadelphia. They are currently seeking co-sponsors for their proposal, marking the latest effort in a series of attempts over recent years to address cannabis legalization in the state.

The proposed legislation aims to expunge criminal records for individuals with past cannabis-related offenses, reinvest funds into communities disproportionately impacted by drug policies, and implement safeguards to prevent predatory marketing and accidental exposure to children. The bill also seeks to set reasonable limits on marijuana potency and create business opportunities within Pennsylvania’s growing cannabis sector.

Krajewski, who chairs the House Health Subcommittee on Health Care, has conducted five hearings to study marijuana programs in other states. The hearings examined the benefits, challenges, and lessons learned from those initiatives. Reflecting on these sessions, Krajewski noted that they included insights from public health professionals, advocates for criminal justice reform, and proponents of social equity.

“We’ve gathered knowledge from experts and observed successes across the country,” Krajewski stated. “Now is the time for Pennsylvania to act, ensuring we don’t fall further behind while creating an opportunity to generate substantial public revenue.”

Recreational cannabis is already legal in 24 other states, including nearly all of Pennsylvania’s neighbors. Public opinion polls indicate widespread bipartisan support among Pennsylvanians for marijuana decriminalization, reflecting the growing demand for change.

Frankel highlighted the adverse effects of marijuana criminalization, particularly in minority communities. He underscored the need to not only legalize cannabis but also to address the longstanding harm caused by prior enforcement policies.

Frankel pointed to challenges faced by other states, such as regulatory shortcomings and legal disputes involving out-of-state marijuana companies, as lessons for Pennsylvania to avoid. “Our proposal is designed to benefit taxpayers, prioritize public health, and uplift communities disproportionately affected by prohibition,” Frankel explained.

Some elements of the proposed legislation align with initiatives previously outlined by Governor Josh Shapiro. Earlier this year, Shapiro included cannabis legalization as part of the state’s executive budget measure, envisioning it as a significant source of new revenue for the state. Although the legislature did not approve the initiative at the time, Shapiro’s administration has projected that a regulated cannabis market could generate $250 million annually. His proposal also called for expunging marijuana-related criminal records and allocating $5 million toward restorative justice programs.

The cannabis industry and its leading players like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) will be following the developments in Pennsylvania to see whether it becomes the latest U.S. state to enact cannabis policy reform.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – CannExpo 2025 to Showcase Innovative Products, Trends in Celebration of All Things Cannabis

CannExpo 2025, Toronto’s Cannabis Lifestyle Show, is set to blaze into the Queen Elizabeth Building at Exhibition Place on March 21-22, 2025. The event will bring together enthusiasts, curious newcomers and professionals from the cannabis industry. An eclectic mix of exhibitors will be featured, from cutting-edge growers and innovative product developers to trendsetting accessory makers and wellness experts. The one-stop-shop for discovering the latest and greatest in the world of cannabis will be buzzing with engaging panels and discussions on hot topics.

To view the full press release, visit https://cnw.fm/m5Kxo

About CannExpo 2025

CannExpo 2025 is more than just an event; it’s a celebration of cannabis. Join us in Toronto as we continue to break down barriers, challenge stereotypes and celebrate the diverse, vibrant world of cannabis culture. Whether you’re a seasoned enthusiast or canna-curious, CannExpo 2025 promises an experience that will expand your horizons and ignite your passion for the plant. For more information, visit www.CannExpo.ca.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Federal Appeals Court Doubtful of Prospects for Suit Challenging Marijuana Ban

A United States appeals court seemed inclined to reject claims made by several marijuana businesses in Massachusetts, which argued that federal laws prohibiting cannabis are no longer constitutional.

The businesses, represented by prominent attorney David Boies, contend that significant changes since the Supreme Court upheld federal marijuana laws in 2005 make the prohibition outdated. Currently, 38 states have legalized medical or recreational cannabis. Boies argued that Congress’s original intent to eliminate cannabis nationwide has shifted, citing legislation and policy changes that reflect a more lenient approach.

Despite his arguments, the judges appeared skeptical. Judge Julie Rikelman, appointed by President Joe Biden, emphasized that Congress still aims to regulate controlled substances, including cannabis, to manage both legal and illegal markets. “That has not changed,” she noted, suggesting that federal regulation remains a valid objective.

The lawsuit, initiated last year, involves Massachusetts-based Canna Provisions, a cannabis retailer; Gyasi Sellers, who operates a cannabis delivery service; Wiseacre Farm, a grower; and Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a publicly traded multistate cannabis company. In July, Judge Mark Mastroianni, appointed by former President Barack Obama, dismissed their case, stating that only the Supreme Court could overturn its 2005 ruling.

In the 2005 ruling, the court held that Congress has the authority under the Commerce Clause to criminalize cannabis possession and use, even in states that legalize it for medical use under the CSA.

The plaintiffs argue that the 2005 rationale has been undermined by subsequent legal and policy developments. They cited a 2021 statement by Justice Clarence Thomas in which he questioned whether the reasoning behind the decision still holds.

Boies also highlighted congressional actions that reflect a changing approach to cannabis. In 2014, Congress prohibited the Justice Department from using federal funds to interfere with state medical cannabis programs. Additionally, in 2010, Congress allowed the use of medical cannabis in Washington, D.C. More recently, the DOJ moved to reclassify cannabis as a Schedule 3 substance, a less severe category than its current Schedule 1 status. A hearing on this potential reclassification is set for January 2025.

Despite these changes, Judge David Barron, another Obama appointee, expressed doubt that these legislative carve-outs indicate a complete shift in federal policy. He questioned how these isolated measures prove that the federal government has abandoned its stance, especially when the overarching prohibition on cannabis sales remains in effect.

This case, Canna Provisions Inc. vs. Garland, continues to highlight the tension between state-level legalization and federal prohibition, a conflict that has yet to be resolved.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — UN Human Rights Commissioner Condemns War on Drugs as a Total Failure

The United Nations High Commissioner for Human Rights (UNHCHR) has urged the global community to reconsider punitive and criminal approaches to drug policy, declaring that the “war on drugs” has been a profound failure.

Speaking at a Warsaw conference that brought together experts and leaders from across Europe, Commissioner Volker Türk noted that current strategies have neither curbed drug use nor deterred drug-related crimes. He called for a shift toward evidence-based policies that center on human rights and prioritize compassion over punishment.

Türk argued that treating drug use as a criminal issue rather than a health matter has marginalized and discriminated against individuals struggling with substance use. He highlighted how punitive approaches often strip people of their rights and dignity, leaving them excluded from society.

According to Türk, these individuals should be included in the policy-making process to create strategies that genuinely reduce harm. Without their input, he warned, efforts to address drug-related issues are unlikely to succeed.

In a video shared on social media, Türk reiterated these views, condemning the destructive impact of punitive drug policies on individuals and communities worldwide. He noted that these policies have failed to address the root causes of drug use while exacerbating harm for those already at risk.

The Commissioner called for transformative solutions guided by the International Guidelines on Drug Policy and Human Rights. He advocated for evidence-driven, gender-sensitive measures rooted in public health, including voluntary access to social and healthcare services. Scapegoating and stigmatization, he emphasized, only deepen the challenges faced by individuals and communities affected by drug use.

Türk’s remarks align with a statement issued earlier by UN experts, working groups, and special rapporteurs. That statement criticized the war on drugs for contributing to severe human rights abuses documented by various UN entities. The experts called for a shift from punishment to support and urged governments to invest in evidence-based programs like prevention, harm reduction, and treatment. These efforts, they stressed, must adhere to human rights norms and prioritize community welfare.

The UN experts also referenced reports encouraging governments to move away from criminalization and adopt harm-reduction strategies. These include drug-checking services, supervised consumption areas, and the availability of naloxone and other overdose-reversal medications. The reports suggested that over-criminalization and stigma are significant barriers to achieving better health outcomes. By addressing these systemic issues, policymakers can develop more effective approaches to drug-related challenges.

Switching from prohibition to legalization and allowing companies like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) to operate can be a good beginning which can then be followed by other measures to undo the harms caused by prohibition policies.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Suggests Marijuana Use Could Trigger Epigenetic Changes

A recent study published in the journal Molecular Psychiatry has explored how marijuana use might influence the epigenome in the human body. The epigenome, often described as a system of switches, regulates how genes are activated or deactivated, shaping bodily functions.

According to Lifang Hou, a Northwestern University epidemiologist, the study identified a connection between multiple epigenetic markers and long-term cannabis use.

The researchers examined more than 1000 participants who had been involved in an earlier long-term study, which included surveys about their marijuana use spanning two decades. Participants who were between 18 and 30 years old at the study’s outset provided blood samples during two specific intervals—15 years and 20 years into the study.

These samples allowed the researchers to analyze changes in DNA methylation, an epigenetic mechanism where methyl groups are added or removed from DNA. While this modification does not alter the DNA sequence, it can influence gene activity by affecting how easily cells can interpret genetic instructions.

Lifestyle and environmental factors, including marijuana use, can induce such methylation alterations, which can have far-reaching implications, including potential transmission to future generations. Blood samples provide a snapshot of both recent and historical exposures to such factors, making them a valuable tool for this kind of research.

The study revealed associations between cannabis use and numerous epigenetic markers. For instance, in blood samples collected at the 15-year mark, 22 markers were linked to recent marijuana use, while 31 were linked to long-term use. By the 20-year point, researchers identified 132 markers tied to recent cannabis use and 16 linked to long-term use.

Interestingly, one of these markers had previously been associated with tobacco use, suggesting a potential overlap in how the body regulates epigenetic responses to both substances.

Hou and her team noted that some of the epigenetic changes identified have been connected to processes such as cellular growth, hormone signaling, immune responses, substance use disorders, and neurological conditions like bipolar disorder and schizophrenia. However, the study does not establish a direct causal relationship between marijuana use and these changes or health issues.

The findings offer new insights into how marijuana may influence epigenetic factors, according to Drew Nannini, another epidemiologist involved in the study. He emphasized the need for additional research across diverse populations to confirm these associations. Investigating how marijuana affects age-related health issues could also shed light on its long-term health impacts.

This call for additional research is partly the reason why the broader marijuana industry, including firms like SNDL Inc. (NASDAQ: SNDL), has for long advocated for sweeping regulatory changes at the federal level so that it is easier to study marijuana and enable state-level and federal authorities to tweak marijuana laws based on the available science about the benefits and actual risks of this substance.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — How Cannabis Firms Can Leverage the Ongoing MJBizCon

Marijuana industry leaders have countless opportunities to form connections and secure business deals at this year’s MJBizCon. MJBizCon 2024 kicked off on Tuesday at the Las Vegas Convention Center, starting with preshow sessions and running through Friday.

To make the most of the world’s largest marijuana business event, it’s essential to arrive with a strategy but also stay adaptable for unforeseen opportunities, according to seasoned attendees who’ve successfully navigated the event.

According to Azuca CEO Kim Sanchez Rael, flexible scheduling is vital since some of the best opportunities come from unexpected encounters. For instance, an impromptu conversation during a preshow lunch at a prior MJBizCon led to a partnership with Wana Brands, a major edibles manufacturer.

Exhibitions have also proven beneficial for Azuca as they provide visibility and a base for meetings. Sanchez notes that being present at a booth allows her company to showcase products, engage with attendees, and even test interest in items not yet launched.

Before the event, Azuca engages in targeted outreach through email campaigns, social media platforms like LinkedIn, and word-of-mouth connections. Sanchez and her team also prearrange meetings with businesses they’re interested in partnering with, ensuring their time at the event is productive.

Another MJBizCon veteran who emphasizes the need for planning is Joe Salome, CEO of Georgia Hemp Co. He recommends researching the exhibitor map in advance to prioritize specific companies and objectives.

However, both Sanchez and Salome agree that maintaining some flexibility is crucial, as chance meetings can result in valuable connections. Salome recounts instances where unplanned interactions at a bar or networking event turned into meaningful business discussions.

Networking at MJBizCon is not limited to the show floor. Preconference breakfasts, lunches, and after-parties are prime opportunities to meet industry professionals. Sanchez Rael advises teams to split up during these events to maximize their networking reach. Salome underscores the importance of attending these gatherings, even when exhaustion sets in, as they often yield unexpected benefits.

MJBizCon is especially valuable for businesses from emerging marijuana markets. Salome points out that in regions like Georgia, where industry infrastructure is still developing, the event offers a chance to connect with suppliers, manufacturers, and other key players. He recalls his first MJBizCon experience in 2015, which helped his company build long-lasting relationships and gain insights from more established markets.

Sometimes, connections made at the event don’t bear fruit until much later. For instance, Jon Spadafora, who launched Flower Union, credits a product introduction at MJBizCon 2022 as the inspiration behind his new edibles line. Conversations with Sanchez on the exhibit floor and at after-parties helped shape his vision, ultimately leading to the creation of a unique product line.

Although MJBizCon is an excellent venue for finding potential partners, industry veterans caution against rushing into agreements. Salome recommends thoroughly evaluating potential collaborators to ensure they align with long-term goals. He suggests holding off on finalizing deals at the event, as emotions can run high in such an environment. Instead, use the convention as an opportunity to gather information and ideas to implement later.

For established firms like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), every opportunity to interact with other members of the cannabis industry is welcome since avenues for brand promotion can arise.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Prices Gradually Reduce as Ohio’s Legal Market Grows

Data released by the Ohio Division of Cannabis Control shows that the price of marijuana has slowly been reducing since adult-use sales were launched this past summer. Dispensaries have reported slow-starts to the recreational program, indicating that vendor costs, confusion among consumers, and the state’s regulations may have contributed to this.

Under state law, licensed dispensaries aren’t allowed to sell marijuana cultivated or purchased outside the state. This has led to a decrease in vendor prices. State records also show that when adult-use sales were launched in August, the manufactured sales average for marijuana product was $31.06 while the average cost of one-tenth ounce of flower was $26.59.

As of last week, the manufactured sales average was $28.70 while the average cost of one-tenth ounce of flower was $21.72.

Terrasana’s director of marketing Nikki Stanley revealed that while they were seeing more traffic after recreational use of marijuana was launched, it still didn’t meet the expectations. Prior to the state approving Issue 2 which allowed individuals aged 21 and above to legally cultivate and use cannabis, most Ohioans were travelling to Michigan to get their marijuana fix.

Even after the recreational-use law going into effect, it appears residents in Ohio are still travelling to Michigan for marijuana. Data from Headset shows that in the last 2 years, Michigan’s marijuana market has recorded over $263 million in total sales.

With regard to sales, $178.5 million in total product sales had been recorded in Ohio as of last week.

Stanley has revealed though that dispensary marijuana prices have also been affected by potency, with higher THC content pushing prices higher. This has made products with higher potency very popular among consumers and while there’s a lot that makes a product good, new consumers seem hell bent on getting products with the highest THC.

The state’s recreational use program imposes a 10% excise tax on all adult-use purchases, with towns that have dispensaries operating in their jurisdictions receiving 36% of the funds generated.

The state has also allocated some taxes towards a substance abuse and addiction fund and a social equity fund, among others.

In addition to this, the program applies a sales tax to cannabis purchases. While the base tax rate is about 5.2% in the state, counties are allowed to impose additional sales taxes on purchases. In Green County, the total tax rate as of this year is 6.75% while in Montgomery County, it’s 7.5%.

The trend being witnessed in Ohio mirrors to a large degree what other jurisdictions in which leading firms like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) operate saw as the markets in which they are licensed had just launched.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study: Utah’s Medical Cannabis Legalization Lowered Opioid Use by Patients with Chronic Pain

A recent study examining the use of prescribed opioids in Utah after medical cannabis legalization in the state highlights a significant reduction in opioid consumption among patients managing chronic pain. The findings also show a substantial decline in opioid prescription-related deaths since Utah authorized medical marijuana in 2018.

The study highlights the increasing use of cannabis for pain relief and its potential to lessen opiate dependence. It concludes that cannabis could be a promising option as healthcare providers explore safer methods for managing pain, especially for individuals with chronic pain conditions.

The Utah study analyzed 186 chronic pain patients, using data from medical cannabis dispensary transactions and corresponding medical records. The information was de-identified and processed using a HIPAA-compliant system developed by MSA.

The participant group included slightly more females (54%) than males (45%), with the majority (87%) being white. Ages ranged between 23 and 89 years, with an average age of 49. Nearly all participants (98.9%) resided in Utah, while a small portion came from New Mexico and Oregon.

The patients in the study experienced various types of chronic pain. Over half (57%) suffered from musculoskeletal pain, while others dealt with visceral pain (19%), orofacial pain and headache (13%), primary pain (4%), neuropathic pain (3%), and postsurgical or post-traumatic pain (2%).

More than 84% of participants decreased their morphine milligram equivalents (MME), a measure of opioid use. In particular, there was a 53.1% average reduction. Before starting on medical marijuana, the mean opioid use was 3,832 MME per month, which fell to 1,798 MME per month after beginning cannabis treatment.

Patients with musculoskeletal pain accounted for the majority of those who reduced opioid use, while individuals with neuropathic pain experienced the most significant reductions.

Interestingly, the study found that patients with orofacial pain or chronic headaches showed a 20.6% increase in opioid use, while other conditions saw reductions ranging from 10.9% to 73.5%. Additionally, individuals who smoked tobacco before using cannabis reported higher opioid use after starting cannabis treatment. This suggests that specific conditions and behaviors may influence the effectiveness of marijuana as a substitute for opioids.

While the findings show promising results linking medical cannabis to fewer overdose deaths and lower opioid use in Utah, the researchers stressed the need for further investigation. They recommend larger and more diverse studies to validate the findings and improve marijuana-based treatment regimens. They also recommended future research to explore optimal cannabinoid dosages and their effects on different populations.

As more of these studies are undertaken and published, the full extent to which medical cannabis products from various licensed companies like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) are helping patients will gradually be documented.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Federal Court Upholds Ban on Cannabis Advertising in Mississippi

Mississippi’s medical cannabis businesses are prohibited from advertising on billboards or any other platforms due to marijuana’s federal status as an illegal substance, according to a recent decision by an appeals court.

The owner of Tru Source Medical Marijuana, a medical cannabis store operating in Olive Branch, Mississippi, contested this restriction. He claimed that since state law allows the sale of marijuana, the First Amendment should protect medical cannabis businesses’ advertising rights.

However, on Friday, a three-judge bench from the 5th Circuit Court of Appeals ruled against the dispensary owner. The court referred to the federal Controlled Substances Act (CSA), which has classified marijuana as an illegal drug since 1970, banning its production, distribution, and possession. The ruling emphasized that federal law takes precedence and that Mississippi’s restrictions on advertising are consistent with this overarching legal framework.

“Mississippi is not subject to constitutional barriers in limiting commercial speech that pertains to unlawful activities,” the judges stated in their decision.

The state attorney general welcomed the ruling, describing the state’s advertising restrictions as reasonable. MaryAsa Lee, a spokesperson for the office, highlighted that the decision reinforces the state’s efforts to regulate medical cannabis advertising through various media, including broadcast, digital platforms, and print.

Tru Source CEO and founder, Clarence Cocroft II, filed a lawsuit in 2023 to contest the ban on advertising through text messages, mass emails, social media, broadcast, billboards, or print.

Cocroft expressed frustration over the decision, noting that the restrictions make it challenging to reach potential clients and educate the public about the state’s medical cannabis program. Despite the setback, Cocroft stated that he remains determined to continue advocating for equitable treatment of medical cannabis businesses.

Although direct advertising is heavily restricted, the state does allow businesses to maintain social media profiles and websites that provide information about their locations and product offerings. Additionally, businesses can list their information in business directories and phone books and include marijuana imagery in their logos. They are also permitted to sponsor advocacy or charitable events.

Cocroft’s legal representation, the Institute for Justice, a not-for-profit law firm, is exploring further legal options. The firm is considering asking the appeals court to review the case or potentially escalating the matter to the apex court. Ari Bargil, an attorney from the firm, criticized the contradictory stance of the state, arguing that it’s unreasonable to create a legal market for medical cannabis while relying on federal law to restrict communication between businesses and consumers.

Established marijuana firms like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) operating in other jurisdictions understand the frustrations that come with marijuana advertising restrictions in a highly competitive environment. The industry hopes that firms in Mississippi find creative ways to reach their potential clients without breaking any existing laws.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com